🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of members share comparison images, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to fines, prosecution or prison.

Platform Reaction and Content Removal

Based on TikTok, the platform has taken down violative content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Trading Activities

Investigations also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of users, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

After moments of entering one group, a seller posted contact information, where most transactions occur. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, posts display black plastic packages with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how long a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to potentially significant health risks”.